Atorvastatin Placebo

DRUG3 trials

Sponsors

Pfizer, Nemours Children's Clinic, shmuel fuchs

Conditions

Diabetes Mellitus, Insulin-DependentHypercholesterolemiaPsoriasisRheumatoid Arthritis

Phase 2

Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550

CompletedNCT01059864

PfizerRheumatoid Arthritis

Start: 2010-02-28End: 2010-11-30Updated: 2012-12-13

Phase 3

Statins in Children With Type 1 Diabetes and Hypercholesterolemia

CompletedNCT01236365

Nemours Children's ClinicDiabetes Mellitus, Insulin-Dependent, Hypercholesterolemia

Start: 2010-10-31End: 2014-11-30Updated: 2019-06-25

Influence of Atorvastatin on Psoriasis Severity and Endothelial Function

WithdrawnNCT01527097

shmuel fuchsPsoriasis

Start: 2012-08-31End: 2015-04-30Updated: 2015-11-17

Related Papers

Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinib

Arthritis Research & Therapy2024-08-273 citations

Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data.

2024-05-025 citations

Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis Receiving Tofacitinib

The Journal of Rheumatology2023-07-155 citations

Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL Surveillance.

2023-03-1781 citations

Fracture in clinical studies of tofacitinib in rheumatoid arthritis.

2022-12-279 citations

Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs.

2022-12-175 citations

Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial.

2022-12-05100 citations

Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment.

2021-12-067 citations

Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme

RMD Open2020-10-01169 citations

Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials.

2020-08-2013 citations

Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 9.5 Years.

2019-03-2817 citations

Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials.

2017-01-31279 citations